Why is Biofil Chemicals falling/rising?

As of 22-Jul, Biofil Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 46.00, reflecting a decrease of 0.8, or 1.71%. The stock has underperformed its sector today, and it is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has dropped by 2.95%, and its year-to-date performance shows a significant decline of 19.30%. Additionally, the company has reported weak long-term fundamental strength, with a -20.95% CAGR growth in operating profits over the last five years and a low return on equity of 4.50%. These factors contribute to the stock's negative movement, despite a recent increase in delivery volume.
In the broader market context, the Sensex has only decreased by 0.47% over the past week, indicating that Biofil's decline is more pronounced than the overall market. The stock's performance has been notably poor over longer periods, with a one-year return of -28.05%, compared to the Sensex's modest gain of 2.09%. This underperformance is compounded by the company's flat results and a significant drop in net sales, which have fallen by 33.62%. The combination of weak financial metrics and a lack of institutional support suggests that investor confidence is low, further driving the stock's decline.